McMillan MT, Reyngold M, Crane CH, O'Brien DAR, et al. A phase II trial of hepatic ablation of metastases to modulate and enhance immunotherapy response in non-small cell lung cancer (HAMMER-NSCLC). BMC Cancer 2025;25:1408.
PMID: 40898159